Joan Vaughan
11Patents
5h-index
21Co-inventors
66Inventor score
Filing activity: Aug 31, 1987 → Jul 17, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4973577A | FSH-releasing peptides | Human Necessities | 83 | Expired |
| US5032507A | Potentiation of erythropoiesis | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6838274B2 | Urocortin proteins and uses thereof | Human Necessities | 11 | Expired |
| US6214797A | Urocortin peptides, nucleic acid encoding same methods for using same | Human Necessities | 11 | Expired |
| US5049655A | Melanin-concentrating hormones | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4843064A | GRF analogs V | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5449766A | DNA encoding NEI and NGE peptides | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7223846B2 | Urocortin proteins and uses thereof | Human Necessities | 2 | Expired |
| US7638607B2 | Urocortin proteins and uses thereof | Human Necessities | 1 | Active |
| US9572866B2 | Urocortin 2 analogs and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8044025B2 | Urocortin proteins and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.